Cinnamophilin ameliorates testosterone-induced prostatic hyperplasia and fibrosis by regulating ۵α-reductase and TGF-β/Smad signaling pathway

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 37

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-1_012

تاریخ نمایه سازی: 19 آذر 1404

چکیده مقاله:

Objective(s): Androgen and TGF-β۱/Smad signaling pathways play important roles in epithelial-mesenchymal transition (EMT), fibrosis, and the development of benign prostatic hyperplasia (BPH). Cinnamophilin is extracted from Cinnamomum philippinense. The anti-proliferative and anti-fibrosis effects of cinnamophilin on the prostate remain unclear. This study aimed to investigate the therapeutic effects and molecular mechanism of action of cinnamophilin on prostate growth in testosterone propionate (TP)-treated mice.Materials and Methods: The study was conducted both in vivo and in vitro. TP was injected subcutaneously to induce prostate enlargement and growth. Cinnamophilin (۴۰ mg/kg) was orally administered once a day in TP (۷.۵ mg/ kg)-treated mice for ۲۸ days. The morphological characteristics and fibrosis of the prostate were examined by H&E (Hematoxylin and Eosin) and Masson’s trichrome stain. Protein expression was determined by Western blot. BPH-۱ and WPMY-۱ cells were treated with different concentrations of cinnamophilin (۱–۱۰۰ μM). Results: Cinnamophilin (۴۰ mg/kg) significantly reduced prostate weight and prostate index in animal models. Cinnamophilin inhibited the protein expression of ۵α-reductase type II and prostate-specific antigen (PSA) in TP-treated mice. Cinnamophilin reversed morphological changes, EMT, and fibrosis in TP-treated mice. Cinnamophilin increased E-cadherin but decreased N-cadherin, vimentin, fibronectin, α-SMA, TGFBR۲, TGF-β۱, p-Smad۲/۳, collagen I, collagen III, and collagen IV protein expressions. The expression of Smad۲/۳ was not significantly different among these groups. Cinnamophilin (۱۰۰ μM) inhibited proliferation at ۴۸ hr in BPH-۱ and WPMY-۱ cells. Conclusion: These findings suggest that cinnamophilin inhibits prostate growth and mitigates EMT and fibrosis by regulating TGFβ/Smad signaling pathways.

نویسندگان

Di Han

College of Chemistry and Bio-engineering, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

Chung-Yi Chen

School of Medical and Health Sciences, Fooyin University, Daliao, Kaohsiung ۸۳۱۰۲, Taiwan

XiangPeng Huang

School of Clinical Medicine, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

Yi Liu

School of Clinical Medicine, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

Hui Sun

College of Chemistry and Bio-engineering, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

YiDan Li

College of Chemistry and Bio-engineering, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

ManYu Liao

College of Basic Medical Sciences, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

JiaYi Cai

College of Chemistry and Bio-engineering, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

Jing Liu

School of Clinical Medicine, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

WenHui Li

School of Clinical Medicine, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

Peng Zhang

College of Basic Medical Sciences, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

ZhengPing Wu

College of Basic Medical Sciences, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

Chi-Ming Liu

College of Basic Medical Sciences, Yichun University, Yichun, Jiangxi Province ۳۳۶۰۰۰, China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Langan RC. Benign prostatic hyperplasia. Prim Care ۲۰۱۹; ۴۶:۲۲۳-۲۳۲ ...
  • Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, ...
  • Liu D, Li C, Li Y, Zhou L, Li J, ...
  • Collaborators GBDBPH. The global, regional, and national burden of benign ...
  • Lucia MS, Lambert JR. Growth factors in benign prostatic hyperplasia: ...
  • Udensi UK, Tchounwou PB. Oxidative stress in prostate hyperplasia and ...
  • Kwon Y. Use of saw palmetto (Serenoa repens) extract for ...
  • Goncharov AP, Vashakidze N, Kharaishvili G. Epithelial-mesenchymal transition: A fundamental ...
  • Lu T, Lin WJ, Izumi K, Wang X, Xu D, ...
  • Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer ...
  • Xu C, Xu Y, Shen Z, Zhou H, Xiao J, ...
  • Lin D, Luo C, Wei P, Zhang A, Zhang M, ...
  • Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid ...
  • Lee EJ, Chen HY, Lee MY, Chen TY, Hsu YS, ...
  • Yu SM, Ko FN, Wu TS, Lee JY, Teng CM. ...
  • Hsiao G, Teng CM, Sheu JR, Cheng YW, Lam KK, ...
  • Tai SH, Lin YW, Huang TY, Chang CC, Chao LC, ...
  • Jin BR, Kim HJ, Na JH, Lee WK, An HJ. ...
  • Hsui Y, Chen H, Chen C, Chen C. Chemical constituents ...
  • Li Y, Tu B, Wang Z, Shao Z, Fu C, ...
  • Chen TY, Tai SH, Lee EJ, Huang CC, Lee AC, ...
  • Chihomvu P, Ganesan A, Gibbons S, Woollard K, Hayes MA. ...
  • Angwa LM, Jiang Y, Pei J, Sun D. Anti-oxidant phytochemicals ...
  • Liu J, Shimizu K, Kondo R. Anti-androgenic activity of fatty ...
  • Liao S, Hiipakka RA. Selective inhibition of steroid ۵ alpha-reductase ...
  • Insumrong K, Ingkaninan K, Waranuch N, Tanuphol N, Wisuitiprot W, ...
  • But MG, Tero-Vescan A, Puscas A, Jitca G, Marc G. ...
  • Afify H, Abo-Youssef AM, Abdel-Rahman HM, Allam S, Azouz AA. ...
  • Gopalakrishnan S, Dhaware M, Sudharma AA, Mullapudi SV, Siginam SR, ...
  • He H, Wang H, Chen X, Zhong Y, Huang XR, ...
  • Al-Trad B, Aljabali A, Al Zoubi M, Shehab M, Omari ...
  • Inui N, Sakai S, Kitagawa M. Molecular pathogenesis of pulmonary ...
  • Yao Y, Chen R, Wang G, Zhang Y, Liu F. ...
  • Qiu D, Song S, Chen N, Bian Y, Yuan C, ...
  • Marconi GD, Fonticoli L, Rajan TS, Pierdomenico SD, Trubiani O, ...
  • Huang Y, Hong W, Wei X. The molecular mechanisms and ...
  • Royuela M, De Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile ...
  • Wang Z, Zhang Y, Zhao C, Li Y, Hu X, ...
  • Hagenlocher Y, Satzinger S, Civelek M, Feilhauer K, Koninger J, ...
  • Mitamura Y, Murai M, Mitoma C, Furue M. NRF۲ activation ...
  • نمایش کامل مراجع